CD63 and non-small cell lung carcinoma: Consistently, an increasing of CD63 protein level in wtEGFR-expressing NSCLC cells was observed in a concentration-dependent manner following osimertinib treatment indicated by Western blot (Fig. 4d, Additional file: Fig. S3a).